Posts

FDA approved abiraterone acetate tablets plus prednisone for metastatic high-risk CSPC

 

  • FDA approved abiraterone acetate (Zytiga, Janssen Biotech Inc.) tablets in combination with prednisone for metastatic high-risk castration-sensitive prostate cancer (CSPC). More Information.